{"nct_id":"NCT04129502","title":"TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2020-01-10","start_date_type":"ACTUAL","primary_completion_date":"2026-10-31","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["TAK"]}